Is Apyx Medical Stock a Good Investment?
Apyx Medical Investment Advice | APYX |
- Examine Apyx Medical's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Apyx Medical's leadership team and their track record. Good management can help Apyx Medical navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Apyx Medical's business and its evolving consumer preferences.
- Compare Apyx Medical's performance and market position to its competitors. Analyze how Apyx Medical is positioned in terms of product offerings, innovation, and market share.
- Check if Apyx Medical pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Apyx Medical's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Apyx Medical stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Apyx Medical is a good investment.
Sell | Buy |
Sell
Market Performance | Insignificant | Details | |
Volatility | Very risky | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Apyx Medical Stock
Researching Apyx Medical's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 16.0% of the company shares are held by company insiders. The book value of Apyx Medical was presently reported as 0.77. The company recorded a loss per share of 0.82. Apyx Medical had not issued any dividends in recent years.
To determine if Apyx Medical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Apyx Medical's research are outlined below:
| Apyx Medical had very high historical volatility over the last 90 days | |
| Apyx Medical may become a speculative penny stock | |
| The company reported the previous year's revenue of 52.35 M. Net Loss for the year was (18.85 M) with profit before overhead, payroll, taxes, and interest of 29.13 M. | |
| Apyx Medical currently holds about 20.06 M in cash with (5.25 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.58. | |
| Apyx Medical has a poor financial position based on the latest SEC disclosures | |
| Roughly 16.0% of the company shares are held by company insiders | |
| Latest headline from globenewswire.com: Apyx Medical Corporation Reports Third Quarter 2024 Financial ResultsUpdates Full Year 2024 Financial Outlook and Introduces Full Year 2025 Financial Outlook |
Apyx Medical Quarterly Good Will |
|
Apyx Medical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Apyx Medical. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Apyx Medical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 21st of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 21st of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Apyx Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Apyx Medical's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2018-05-14 | 2018-03-31 | -0.02 | -0.03 | -0.01 | 50 | ||
2017-08-02 | 2017-06-30 | -0.03 | -0.04 | -0.01 | 33 | ||
2016-10-26 | 2016-09-30 | -0.02 | -0.01 | 0.01 | 50 | ||
2015-11-04 | 2015-09-30 | -0.06 | -0.07 | -0.01 | 16 | ||
2014-08-05 | 2014-06-30 | -0.02 | -0.03 | -0.01 | 50 | ||
2009-08-10 | 2009-06-30 | 0.02 | 0.01 | -0.01 | 50 | ||
2009-11-09 | 2009-09-30 | 0.01 | -0.0021 | -0.0121 | 121 | ||
2023-11-09 | 2023-09-30 | -0.11 | -0.13 | -0.02 | 18 |
Know Apyx Medical's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Apyx Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Apyx Medical backward and forwards among themselves. Apyx Medical's institutional investor refers to the entity that pools money to purchase Apyx Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Rathbone Brothers Plc | 2024-06-30 | 251.3 K | Perkins Capital Management Inc | 2024-09-30 | 217.5 K | Renaissance Technologies Corp | 2024-09-30 | 203.3 K | Bridgeway Capital Management, Llc | 2024-09-30 | 140.4 K | Kestra Advisory Services, Llc | 2024-06-30 | 124.2 K | Caption Management, Llc | 2024-09-30 | 115.5 K | State Street Corp | 2024-06-30 | 109.3 K | Dimensional Fund Advisors, Inc. | 2024-09-30 | 108.3 K | Northern Trust Corp | 2024-09-30 | 103.4 K | Archon Capital Management Llc | 2024-06-30 | 3.1 M | Royce & Associates, Lp | 2024-09-30 | 2.6 M |
Apyx Medical's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 54.4 M.Market Cap |
|
Apyx Medical's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.24) | (0.22) | |
| Return On Capital Employed | (0.26) | (0.25) | |
| Return On Assets | (0.24) | (0.22) | |
| Return On Equity | (0.70) | (0.67) |
Determining Apyx Medical's profitability involves analyzing its financial statements and using various financial metrics to determine if Apyx Medical is a good buy. For example, gross profit margin measures Apyx Medical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Apyx Medical's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Apyx Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Apyx Medical. Check Apyx Medical's Beneish M Score to see the likelihood of Apyx Medical's management manipulating its earnings.
Evaluate Apyx Medical's management efficiency
Apyx Medical has return on total asset (ROA) of (0.2183) % which means that it has lost $0.2183 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1025) %, meaning that it created substantial loss on money invested by shareholders. Apyx Medical's management efficiency ratios could be used to measure how well Apyx Medical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to -0.22 in 2024. Return On Capital Employed is likely to rise to -0.25 in 2024. At this time, Apyx Medical's Total Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 1.8 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 8.2 M in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.78 | 0.76 | |
| Tangible Book Value Per Share | 0.78 | 0.66 | |
| Enterprise Value Over EBITDA | (4.72) | (4.96) | |
| Price Book Value Ratio | 3.40 | 3.23 | |
| Enterprise Value Multiple | (4.72) | (4.96) | |
| Price Fair Value | 3.40 | 3.23 | |
| Enterprise Value | 100.9 M | 66.4 M |
The strategic vision of Apyx Medical management plays a critical role in its financial performance. By evaluating this vision, we provide insights into the stock's growth potential.
Beta 1.209 |
Basic technical analysis of Apyx Stock
As of the 27th of November, Apyx Medical shows the Mean Deviation of 3.25, downside deviation of 3.55, and Risk Adjusted Performance of 0.0496. Apyx Medical technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Apyx Medical's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Apyx Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Apyx Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Apyx Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Apyx Medical's Outstanding Corporate Bonds
Apyx Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Apyx Medical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Apyx bonds can be classified according to their maturity, which is the date when Apyx Medical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| US03835VAH96 Corp BondUS03835VAH96 | View | |
| Aptiv 435 percent Corp BondUS03835VAG14 | View | |
| APTIV PLC 44 Corp BondUS03835VAF31 | View | |
| APTV 31 01 DEC 51 Corp BondUS03835VAJ52 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| ATR 36 15 MAR 32 Corp BondUS038336AA11 | View |
Understand Apyx Medical's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Apyx Medical's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0496 | |||
| Market Risk Adjusted Performance | 0.2987 | |||
| Mean Deviation | 3.25 | |||
| Semi Deviation | 3.27 | |||
| Downside Deviation | 3.55 | |||
| Coefficient Of Variation | 1861.4 | |||
| Standard Deviation | 5.18 | |||
| Variance | 26.81 | |||
| Information Ratio | 0.0289 | |||
| Jensen Alpha | 0.158 | |||
| Total Risk Alpha | (0.54) | |||
| Sortino Ratio | 0.0421 | |||
| Treynor Ratio | 0.2887 | |||
| Maximum Drawdown | 32.02 | |||
| Value At Risk | (6.45) | |||
| Potential Upside | 9.38 | |||
| Downside Variance | 12.6 | |||
| Semi Variance | 10.7 | |||
| Expected Short fall | (4.40) | |||
| Skewness | 2.32 | |||
| Kurtosis | 9.07 |
| Risk Adjusted Performance | 0.0496 | |||
| Market Risk Adjusted Performance | 0.2987 | |||
| Mean Deviation | 3.25 | |||
| Semi Deviation | 3.27 | |||
| Downside Deviation | 3.55 | |||
| Coefficient Of Variation | 1861.4 | |||
| Standard Deviation | 5.18 | |||
| Variance | 26.81 | |||
| Information Ratio | 0.0289 | |||
| Jensen Alpha | 0.158 | |||
| Total Risk Alpha | (0.54) | |||
| Sortino Ratio | 0.0421 | |||
| Treynor Ratio | 0.2887 | |||
| Maximum Drawdown | 32.02 | |||
| Value At Risk | (6.45) | |||
| Potential Upside | 9.38 | |||
| Downside Variance | 12.6 | |||
| Semi Variance | 10.7 | |||
| Expected Short fall | (4.40) | |||
| Skewness | 2.32 | |||
| Kurtosis | 9.07 |
Consider Apyx Medical's intraday indicators
Apyx Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Apyx Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 2602.58 | |||
| Daily Balance Of Power | 0.1111 | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 1.44 | |||
| Day Typical Price | 1.44 | |||
| Price Action Indicator | 0.02 | |||
| Period Momentum Indicator | 0.01 |
Apyx Stock media impact
Far too much social signal, news, headlines, and media speculation about Apyx Medical that are available to investors today. That information is available publicly through Apyx media outlets and privately through word of mouth or via Apyx internal channels. However, regardless of the origin, that massive amount of Apyx data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Apyx Medical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Apyx Medical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Apyx Medical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Apyx Medical alpha.
Apyx Medical Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Apyx Medical can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Apyx Medical Corporate Executives
Elected by the shareholders, the Apyx Medical's board of directors comprises two types of representatives: Apyx Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Apyx. The board's role is to monitor Apyx Medical's management team and ensure that shareholders' interests are well served. Apyx Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Apyx Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Already Invested in Apyx Medical?
The danger of trading Apyx Medical is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Apyx Medical is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Apyx Medical. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Apyx Medical is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additional Tools for Apyx Stock Analysis
When running Apyx Medical's price analysis, check to measure Apyx Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apyx Medical is operating at the current time. Most of Apyx Medical's value examination focuses on studying past and present price action to predict the probability of Apyx Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apyx Medical's price. Additionally, you may evaluate how the addition of Apyx Medical to your portfolios can decrease your overall portfolio volatility.